Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 16 May 2022 for Pieris Pharmaceuticals, INC., €9,885.
Filing timeline
BuySaleTim Demuth
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Tim Demuth: trading record in brief
Our data holds just one disclosure by Tim Demuth, dated 16 May 2022, reporting an open-market purchase worth €9,885 in Palvella Therapeutics, Inc. Further filings will be added here. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Tim Demuth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 6,000 shares@ US$1.71100.0% of flowCommon StockSEC:0001583648-22-000030:0Canonical exit: 11 Aug 2022 (T+90)
1 of 1 declaration
